Key facts
- It has raised $4.6M across 1 recorded rounds; the latest was Early Stage VC ($4.6M) in Dec 2021.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Genomelink
Create free account
No card required
Funding rounds
1 roundsDec 2021Early Stage VC$4.6M▮
About Genomelink
- Industry
- Other Healthcare Services
PA Mark — not yet priced
Genomelink doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Genomelink shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Genomelink in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.